GSA Capital Partners’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $91K | Buy |
37,239
+12,607
| +51% | +$30.8K | 0.01% | 1623 |
|
|
2025
Q1 | $164K | Buy |
+24,632
| New | +$164K | 0.01% | 1439 |
|
|
2022
Q4 | – | Sell |
-54,582
| Closed | -$871K | – | 1815 |
|
|
2022
Q3 | $871K | Buy |
54,582
+33,293
| +156% | +$531K | 0.12% | 220 |
|
|
2022
Q2 | $293K | Buy |
+21,289
| New | +$293K | 0.04% | 840 |
|
|
2022
Q1 | – | Sell |
-35,704
| Closed | -$779K | – | 1756 |
|
|
2021
Q4 | $779K | Buy |
+35,704
| New | +$779K | 0.1% | 328 |
|
|
2021
Q1 | – | Sell |
-6,699
| Closed | -$367K | – | 1416 |
|
|
2020
Q4 | $367K | Sell |
6,699
-13,767
| -67% | -$754K | 0.06% | 630 |
|
|
2020
Q3 | $468K | Buy |
+20,466
| New | +$468K | 0.08% | 431 |
|
|
2018
Q1 | – | Sell |
-3,325
| Closed | -$35K | – | 1782 |
|
|
2017
Q4 | $35K | Sell |
3,325
-88,500
| -96% | -$932K | ﹤0.01% | 1511 |
|
|
2017
Q3 | $654K | Buy |
91,825
+52,750
| +135% | +$376K | 0.04% | 793 |
|
|
2017
Q2 | $297K | Buy |
39,075
+1,625
| +4% | +$12.4K | 0.02% | 1282 |
|
|
2017
Q1 | $300K | Buy |
+37,450
| New | +$300K | 0.02% | 1384 |
|